Beckers Hospital Review
JUNE 27, 2025
The breach affected patients who received or were scheduled for sleep studies at three Northern Light facilities: Eastern Maine Medical Center, AR Gould Hospital, and Sebasticook Valley Hospital, the health system said in a June 27 statement. Compumedics began mailing individual notices to affected patients on June 27.
pharmaphorum
MAY 24, 2021
All three nations said the introduction of digital medical records, the expansion of telemedicine services and the use of patient data for diagnosis are desirable outcomes of a digital health revolution, while around a third of people in each country are also in favour of greater use of wearable devices to harvest health data.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 23, 2022
A study led by Boston University School of Public Health (BUSPH) and the White River Junction Veterans Affairs Medical Center in Vermont has completed a rigorous analysis to compare the effectiveness of direct acting antivirals on improving symptoms of posttraumatic stress disorder (PTSD). .
pharmaphorum
FEBRUARY 23, 2021
IQWiG sees far less promise in other RWE sources such as electronic medical records and billing records of insurers. Figure 1: AMNOG procedures and findings, 2011-2019. Leela worked as an advisor to the Department of Health and Social Care on the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).
FDA Law Blog: Biosimilars
MAY 13, 2024
Based on a review of premarket submissions made in 2012 through 2019, FDA identified 90 examples of 510(k)s, De Novos, HDEs, and PMAs approved/cleared which utilized RWE in support of regulatory decision-making. Every use of ESD is recorded, as is every behavior that falls within the intended use.
RX Note
MARCH 14, 2023
Often, to find a quick answer for the antibiotic for a certain infectious disease, I will look up National Antimicrobial Guideline, 2019 or Sanford Guide to Antimicrobial Therapy. Example of patients with altered pharmacokinetics (e.g. before the availability of culture or susceptibility testing result).
FDA Law Blog: Biosimilars
OCTOBER 2, 2023
However, the two previous FDA guidance documents, released in May 1998 ( Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products , available here ) and December 2019 ( Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products , available here ), differ from the new guidance.
Expert insights. Personalized for you.
Let's personalize your content